Full Text
PMU72 - ESTIMATED COSTS OF PIVOTAL TRIALS FOR NOVEL THERAPEUTIC AGENTS APPROVED BY THE FDA, 2015-2016

Abstract

Authors

GC Alexander TJ Moore G Anderson H Zhang

Back to Volume 21, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×